NEW YORK, Sept. 14, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer, will present at the Oppenheimer 2nd Annual Diabetes Investment Conference on Thursday, September 21 from 2:15pm -- 2:40pm EDT. The conference is being held at the Jolly Hotel, Madison Towers in New York City.
